Phreesia Revenue 2019-2024 | PHR

Phreesia revenue from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Phreesia Annual Revenue
(Millions of US $)
2024 $356
2023 $281
2022 $213
2021 $149
2020 $125
2019 $100
2018 $80
Phreesia Quarterly Revenue
(Millions of US $)
2024-07-31 $102
2024-04-30 $101
2024-01-31 $95
2023-10-31 $92
2023-07-31 $86
2023-04-30 $84
2023-01-31 $77
2022-10-31 $73
2022-07-31 $68
2022-04-30 $63
2022-01-31 $58
2021-10-31 $56
2021-07-31 $51
2021-04-30 $48
2021-01-31 $42
2020-10-31 $38
2020-07-31 $35
2020-04-30 $33
2020-01-31 $33
2019-10-31 $33
2019-07-31 $31
2019-04-30 $28
2019-01-31
2018-10-31 $25
2018-07-31 $25
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.098B $0.356B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.263B 0.00
Inspire Medical Systems (INSP) United States $5.580B 174.01
Hims & Hers Health (HIMS) United States $5.276B 134.17
Enovis (ENOV) United States $2.580B 17.49
Privia Health (PRVA) United States $2.530B 210.80
IRhythm Technologies (IRTC) United States $2.313B 0.00
Azenta (AZTA) United States $2.227B 111.05
Omnicell (OMCL) United States $2.043B 66.83
Clover Health Investments (CLOV) United States $1.684B 0.00
10x Genomics (TXG) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.484B 0.00
Butterfly Network (BFLY) United States $0.701B 0.00
Standard BioTools (LAB) United States $0.603B 0.00
Talkspace (TALK) United States $0.559B 0.00
Fulgent Genetics (FLGT) United States $0.518B 0.00
Definitive Healthcare (DH) United States $0.491B 85.00
Health Catalyst (HCAT) United States $0.466B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
TruBridge (TBRG) United States $0.239B 69.61
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.075B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Zepp Health (ZEPP) China $0.038B 0.00
Movano (MOVE) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.010B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00